Galaxy Surfactants Ltd. · NSE:GALAXYSURF
Galaxy Surfactants — FY2026 Earnings Presentation
18 slides from Galaxy Surfactants's earnings presentation, May 14, 2026
Slide 1: Exchange filing cover letter for investor presentation
May 14, 2026 National Stock Exchange of India Limited BSE Limited, Exchange Plaza, C-1, Block G, Listing Department, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East) Dalal Street, Mumbai – 400 051 Mumbai- 400001 Scrip Symbol: GALAXYSURF Scrip Code: 540935 Sub: Investor presentation on
Slide 2: Galaxy Surfactants Limited Result Presentation May'26
Galaxy Surfactants Limited Result Presentation May’26
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any se
Slide 4: Company at a Glance
Company at a Glance Extensive R&D Capabilities 7 Strategically Located 215+ Product Grades Facilities with Inhouse 100+ Members Project Execution Capabilities Performance Surfactants: 47+ R&D Centre Specialty Care Products: 168+ Pilot Plant 5 in India Product Application Centre 1 in Egypt 1 in US Pr
Slide 5: Q4 & FY26 Performance Highlights
Q4 & FY26 Performance Highlights
Slide 6: Management Commentary
Management Commentary “Our performance in Q4 and full year FY26 remained resilient despite a highly disrupted operating environment amid the ongoing West Asia conflict, which impacted global supply chains, logistics, and input costs. EBITDA for Q4FY26 stood at ₹122 crore compared to ₹135 crore in Q4
Slide 7: Key Developments
Key Developments 01 04 Consolidated Q4 volumes remained flat YoY, with AMET volumes declined in the mid teens on YoY Specialty Care growing in high single digits on YoY and affected due to geopolitical disruption caused in West offsetting high-single digits decline in Performance Asia for Q4FY26 Sur
Slide 8: Segment Performance Highlights
Segment Performance Highlights Performance Surfactants Revenue Specialty Care Revenue Total Revenue Q4FY26 ₹ 817.3 cr ₹ 497.6 cr ₹ 1,315.0 cr FY26 ₹ 3,340.8 cr ₹ 1,929.6 cr ₹ 5,270.4 cr Volume Summary Q4FY26 FY26 Category wise Performance Surfactant High single-digit decline Mid single-digit decline
Slide 9: Q4FY26 Consolidated Performance
Consolidated Performance Rs in cr Total Revenue EBITDA PAT 1,334 1,315 135 76 124 122 Q4FY26 1,153 62 59 Q4FY25 Q3FY26 Q4FY26 Q4FY25 Q3FY26 Q4FY26 Q4FY25 Q3FY26# Q4FY26 305 5,270 510 497 267 4,249 FY26 FY25 FY26 FY25 FY26 FY25 FY26# #Includes Rs 11.9 cr towards the Statutory Impact of New Labour Cod
Slide 10: Revenue Performance
Revenue Performance Category Customer Region wise Revenue 39% 40% 44% 51% 45% 54% 53% 49% 63% 62% 61% 63% 23% 24% 7% 7% 9% 7% 20% 21% 37% 38% 39% 37% 39% 40% 40% 42% 38% 36% 35% 35% Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Performance Surfactants MNC Customer Local & N
Slide 11: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs. In Crores) Q4FY26 Q4FY25 Y-o-Y Q3FY26 Q-o-Q FY26 FY25 Y-o-Y Net Revenue from Operations 1,314.7 1,144.9 14.8% 1,329.5 -1.1% 5,248.3 4,223.7 24.3% Other Income 0.3 7.8 4.8 22.1 25.8 Total Revenue 1,315.0 1,152.7 14.1% 1,334.3 -1.4% 5,270.4 4,249.5
Slide 12: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (Rs. In Crores) Mar'26 Mar'25 Particulars (Rs. In Crores) Mar'26 Mar'25 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 982.5 839.8 EQUITY Right-of-use assets 182.9 184.3 Equity Share Capital 35.5 35.5 Capital work-in-progress 181.4 261.9 Other Equi
Slide 13: Consolidated Cashflow Statement
Consolidated Cashflow Statement Particulars (Rs. In Crores) FY26 FY25 Cash Flow From Operating Activities : Profit After Tax 267.4 304.9 Operating Profit before working Capital changes 469.3 484.5 Net cash flows generated from/(used) in Operating Activities (A) 332.7 420.5 Net cash flows generated f
Slide 14: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Particulars (Rs. In Crores) Q4FY26 Q4FY25 Y-o-Y Q3FY26 Q-o-Q FY26 FY25 Y-o-Y Net Revenue from Operations 928.3 814.3 14.0% 867.7 7.0% 3,589.1 3,001.3 19.6% Other Income 6.2 6.7 3.9 29.6 26.5 Total Revenue 934.5 820.9 13.8% 871.6 7.2% 3,618.7 3,027.7 19.5% Cost of M
Slide 15: Standalone Balance Sheet
Standalone Balance Sheet Particulars (Rs. In Crores) Mar'26 Mar'25 Particulars (Rs. In Crores) Mar'26 Mar'25 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 690.3 553.5 EQUITY Right-of-use assets 145.4 145.4 Equity Share Capital 35.5 35.5 Capital work-in-progress 176.7 253.9 Other Equity
Slide 16: Standalone Cashflow Statement
Standalone Cashflow Statement Particulars (Rs. In Crores) FY26 FY25 Cash Flow From Operating Activities : Profit After Tax 152.0 173.8 Operating Profit before working Capital changes 272.1 282.7 Net cash flows generated from/(used) in Operating Activities (A) 94.9 295.5 Net cash flows generated from
Slide 17: Managing Volatility in Raw Material Prices and Currency
Managing Volatility in Raw Material Prices and Currency... Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 3,000 94.00 90.00 2,600 86.00 2,200 82.00 1,800 78.00 1,400 74.00 1,000 70.00 LA Price USDINR … through Robust Risk Management Practices Source: Market Prices – ICIS – LOR Sour
Slide 18: Thank You
Thank You Company Investor Relations Advisors : CIN - U74140MH2010PTC204285 CIN No: L39877MH1986PLC039877 Mr. Mandar Chavan / Mr. Rahul Agarwal Mr. Ruchir Soni mandar.chavan@sgapl.net / Email: Ruchir.Soni@galaxysurfactants.com rahul.agarwal@sgapl.net www.galaxysurfactants.com +91 96993 82195 / +91 9